[S01AA13, fusidic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fusidic acid.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be increased when combined with Somatotropin.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be increased when combined with Somatotropin.]
[S03BA01, dexamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Dexamethasone.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be increased when combined with Somatotropin.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be increased when combined with Somatotropin.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be increased when combined with Somatotropin.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be increased when combined with Somatotropin.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be increased when combined with Somatotropin.]
[A10BG03, pioglitazone, Somatotropin may decrease the hypoglycemic activities of Pioglitazone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be increased when combined with Somatotropin.]
[L02AA01, diethylstilbestrol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Diethylstilbestrol.]
[D07XC04, diflucortolone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Difluocortolone.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be increased when combined with Somatotropin.]
[L02AA02, polyestradiol phosphate, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Polyestradiol phosphate.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be increased when combined with Somatotropin.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be increased when combined with Somatotropin.]
[C01BA03, disopyramide, Somatotropin may decrease the hypoglycemic activities of Disopyramide.]
[N07XX02, riluzole, The metabolism of Riluzole can be increased when combined with Somatotropin.]
[N01BB09, ropivacaine, The metabolism of Ropivacaine can be increased when combined with Somatotropin.]
[L01EX01, sunitinib, Somatotropin may decrease the hypoglycemic activities of Sunitinib.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be increased when combined with Somatotropin.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be increased when combined with Somatotropin.]
[N06AA12, doxepin, The metabolism of Doxepin can be increased when combined with Somatotropin.]
[C10AA01, simvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Simvastatin.]
[J01MA05, temafloxacin, The metabolism of Temafloxacin can be increased when combined with Somatotropin.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Terbinafine.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tianeptine.]
[G03CX01, tibolone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Tibolone.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Enalapril.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be increased when combined with Somatotropin.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Somatotropin.]
[N05AX11, zotepine, The metabolism of Zotepine can be increased when combined with Somatotropin.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Iloprost.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be increased when combined with Somatotropin.]
[G03CA03, estradiol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol.]
[G03CC06, estriol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estriol.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Somatotropin can be decreased when used in combination with Conjugated estrogens.]
[G03CC04, estrone, The metabolism of Estrone can be increased when combined with Somatotropin.]
[R03BA09, fluticasone furoate, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone furoate.]
[R03BA05, fluticasone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone.]
[C10AA04, fluvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Ethinylestradiol.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Somatotropin.]
[L04AD02, tacrolimus, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tacrolimus.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Nizatidine.]
[N06AB08, fluvoxamine, The metabolism of Fluvoxamine can be increased when combined with Somatotropin.]
[C01BB03, tocainide, The metabolism of Tocainide can be increased when combined with Somatotropin.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Somatotropin.]
[C10AA03, pravastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pravastatin.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Somatotropin.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be increased when combined with Somatotropin.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cladribine.]
[C01BC04, flecainide, The metabolism of Flecainide can be increased when combined with Somatotropin.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be increased when combined with Somatotropin.]
[D07AC08, fluocinonide, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluocinonide.]
[H02AB03, fluocortolone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ethanol.]
[S01CB05, fluorometholone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluorometholone.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be increased when combined with Somatotropin.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be increased when combined with Somatotropin.]
[L02BB01, flutamide, The metabolism of Flutamide can be increased when combined with Somatotropin.]
[L01BC03, tegafur, The metabolism of Tegafur can be increased when combined with Somatotropin.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ganciclovir.]
[C10AB04, gemfibrozil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be increased when combined with Somatotropin.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be increased when combined with Somatotropin.]
[A10BJ02, liraglutide, Somatotropin may decrease the hypoglycemic activities of Liraglutide.]
[A10BB01, glyburide, Somatotropin may decrease the hypoglycemic activities of Glyburide.]
[A10BB09, gliclazide, Somatotropin may decrease the hypoglycemic activities of Gliclazide.]
[A10BB07, glipizide, Somatotropin may decrease the hypoglycemic activities of Glipizide.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Somatotropin.]
[N05AD01, haloperidol, The metabolism of Haloperidol can be increased when combined with Somatotropin.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Somatotropin.]
[S01BA13, rimexolone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Rimexolone.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Risedronic acid.]
[N06AA02, imipramine, The metabolism of Imipramine can be increased when combined with Somatotropin.]
[L01CD01, paclitaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Paclitaxel.]
[M03BX02, tizanidine, The metabolism of Tizanidine can be increased when combined with Somatotropin.]
[A10BH01, sitagliptin, Somatotropin may decrease the hypoglycemic activities of Sitagliptin.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be increased when combined with Somatotropin.]
[A10BH02, vildagliptin, Somatotropin may decrease the hypoglycemic activities of Vildagliptin.]
[C10AA06, cerivastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cerivastatin.]
[L01XX35, anagrelide, The metabolism of Anagrelide can be increased when combined with Somatotropin.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Stavudine.]
[J05AB13, penciclovir, The metabolism of Penciclovir can be increased when combined with Somatotropin.]
[J04AC01, isoniazid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isoniazid.]
[A10BJ01, exenatide, Somatotropin may decrease the hypoglycemic activities of Exenatide.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ivermectin.]
[N05AH03, olanzapine, The metabolism of Olanzapine can be increased when combined with Somatotropin.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be increased when combined with Somatotropin.]
[C10AA02, lovastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lovastatin.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be increased when combined with Somatotropin.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mefloquine.]
[N05CH01, melatonin, The metabolism of Melatonin can be increased when combined with Somatotropin.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be increased when combined with Somatotropin.]
[A10BA02, metformin, Somatotropin may decrease the hypoglycemic activities of Metformin.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lamivudine.]
[L01BA04, pemetrexed, The metabolism of Pemetrexed can be increased when combined with Somatotropin.]
[L04AX03, methotrexate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methotrexate.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methyldopa.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be increased when combined with Somatotropin.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Somatotropin.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Metoclopramide.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be increased when combined with Somatotropin.]
[N06AX03, mianserin, The metabolism of Mianserin can be increased when combined with Somatotropin.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be increased when combined with Somatotropin.]
[G03XB01, mifepristone, Somatotropin may decrease the hypoglycemic activities of Mifepristone.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Minocycline.]
[C01BD01, amiodarone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be increased when combined with Somatotropin.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be increased when combined with Somatotropin.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be increased when combined with Somatotropin.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Raltegravir.]
[N04BC04, ropinirole, The metabolism of Ropinirole can be increased when combined with Somatotropin.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Naltrexone.]
[M02AA12, naproxen, The metabolism of Naproxen can be increased when combined with Somatotropin.]
[A10BG01, troglitazone, Somatotropin may decrease the hypoglycemic activities of Troglitazone.]
[L01CD02, docetaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Docetaxel.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Letrozole.]
[A10BX02, repaglinide, Somatotropin may decrease the hypoglycemic activities of Repaglinide.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amphotericin B.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Niacin.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be increased when combined with Somatotropin.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Norfloxacin.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ofloxacin.]
[N05AH05, asenapine, The metabolism of Asenapine can be increased when combined with Somatotropin.]
[H02AB05, paramethasone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Paramethasone.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Penicillamine.]
[C04AD03, pentoxifylline, The metabolism of Pentoxifylline can be increased when combined with Somatotropin.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be increased when combined with Somatotropin.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be increased when combined with Somatotropin.]
[A10BA01, phenformin, Somatotropin may decrease the hypoglycemic activities of Phenformin.]
[N03AB02, phenytoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Phenytoin.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Somatotropin.]
[C10AA05, atorvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Atorvastatin.]
[J05AE01, saquinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Saquinavir.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Eprosartan.]
[J01MA11, grepafloxacin, The metabolism of Grepafloxacin can be increased when combined with Somatotropin.]
[A10BG02, rosiglitazone, Somatotropin may decrease the hypoglycemic activities of Rosiglitazone.]
[A03AE01, alosetron, The metabolism of Alosetron can be increased when combined with Somatotropin.]
[J05AE03, ritonavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ritonavir.]
[A10BH03, saxagliptin, Somatotropin may decrease the hypoglycemic activities of Saxagliptin.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Somatotropin.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pitavastatin.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be increased when combined with Somatotropin.]
[H02AB07, prednisone, The serum concentration of the active metabolites of Prednisone can be reduced when Prednisone is used in combination with Somatotropin resulting in a loss in efficacy.]
[P01BA03, primaquine, The metabolism of Primaquine can be increased when combined with Somatotropin.]
[C01BA02, procainamide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procainamide.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibrate.]
[N05AA03, promazine, The metabolism of Promazine can be increased when combined with Somatotropin.]
[C01BC03, propafenone, The metabolism of Propafenone can be increased when combined with Somatotropin.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propofol.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Somatotropin.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propylthiouracil.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Montelukast.]
[P01BC01, quinine, Somatotropin may decrease the hypoglycemic activities of Quinine.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ranitidine.]
[N04BD01, selegiline, The metabolism of Selegiline can be increased when combined with Somatotropin.]
[S02DA03, antipyrine, The metabolism of Antipyrine can be increased when combined with Somatotropin.]
[J01EC02, sulfadiazine, Somatotropin may decrease the hypoglycemic activities of Sulfadiazine.]
[J01EC01, sulfamethoxazole, Somatotropin may decrease the hypoglycemic activities of Sulfamethoxazole.]
[S01AB02, sulfisoxazole, Somatotropin may decrease the hypoglycemic activities of Sulfisoxazole.]
[A10BB04, glibornuride, Somatotropin may decrease the hypoglycemic activities of Glibornuride.]
[A10BC01, glymidine, Somatotropin may decrease the hypoglycemic activities of Glymidine.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tacrine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be increased when combined with Somatotropin.]
[R03DA07, theobromine, The metabolism of Theobromine can be increased when combined with Somatotropin.]
[R03DA04, theophylline, The metabolism of Theophylline can be increased when combined with Somatotropin.]
[P02CA02, thiabendazole, The metabolism of Thiabendazole can be increased when combined with Somatotropin.]
[N05AF04, thiothixene, The metabolism of Thiothixene can be increased when combined with Somatotropin.]
[A10BB05, tolazamide, Somatotropin may decrease the hypoglycemic activities of Tolazamide.]
[V04CA01, tolbutamide, Somatotropin may decrease the hypoglycemic activities of Tolbutamide.]
[S01BA05, triamcinolone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Triamcinolone.]
[C03DB02, triamterene, The metabolism of Triamterene can be increased when combined with Somatotropin.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Triazolam.]
[N05AB06, trifluoperazine, The metabolism of Trifluoperazine can be increased when combined with Somatotropin.]
[R03BA07, mometasone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Mometasone.]
[J01EA01, trimethoprim, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Trimethoprim.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be increased when combined with Somatotropin.]
[A10BH05, linagliptin, Somatotropin may decrease the hypoglycemic activities of Linagliptin.]
[C08DA01, verapamil, The metabolism of Verapamil can be increased when combined with Somatotropin.]
[L01CA02, vincristine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Vincristine.]
[B01AA03, warfarin, The metabolism of Warfarin can be increased when combined with Somatotropin.]
[S01AA13, fusidic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fusidic acid.]
[J05AF01, zidovudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Zidovudine.]
[J05AE02, indinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Indinavir.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pamidronic acid.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ibandronate.]
[L01EK01, axitinib, The metabolism of Axitinib can be increased when combined with Somatotropin.]
[H02AB11, prednylidene, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Prednylidene.]
[L04AX01, azathioprine, The metabolism of Azathioprine can be increased when combined with Somatotropin.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Baclofen.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be increased when combined with Somatotropin.]
[L01AA09, bendamustine, The metabolism of Bendamustine can be increased when combined with Somatotropin.]
[N04BD02, rasagiline, The metabolism of Rasagiline can be increased when combined with Somatotropin.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lercanidipine.]
[N03AX22, perampanel, The metabolism of Perampanel can be increased when combined with Somatotropin.]
[N02CC03, zolmitriptan, The metabolism of Zolmitriptan can be increased when combined with Somatotropin.]
[G04BE03, sildenafil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Sildenafil.]
[A10BH04, alogliptin, Somatotropin may decrease the hypoglycemic activities of Alogliptin.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be increased when combined with Somatotropin.]
[A10BK02, canagliflozin, Somatotropin may decrease the hypoglycemic activities of Canagliflozin.]
[A10AE05, insulin detemir, The therapeutic efficacy of Insulin detemir can be decreased when used in combination with Somatotropin.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be increased when combined with Somatotropin.]
[A10BX05, pramlintide, Somatotropin may decrease the hypoglycemic activities of Pramlintide.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be increased when combined with Somatotropin.]
[A10BJ03, lixisenatide, Somatotropin may decrease the hypoglycemic activities of Lixisenatide.]
[A10BK01, dapagliflozin, Somatotropin may decrease the hypoglycemic activities of Dapagliflozin.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be increased when combined with Somatotropin.]
[L04AA32, apremilast, The metabolism of Apremilast can be increased when combined with Somatotropin.]
[S03BA03, betamethasone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Betamethasone.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be increased when combined with Somatotropin.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Bezafibrate.]
[A10BJ04, albiglutide, Somatotropin may decrease the hypoglycemic activities of Albiglutide.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be increased when combined with Somatotropin.]
[A10BK03, empagliflozin, Somatotropin may decrease the hypoglycemic activities of Empagliflozin.]
[A10BJ05, dulaglutide, Somatotropin may decrease the hypoglycemic activities of Dulaglutide.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be increased when combined with Somatotropin.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be increased when combined with Somatotropin.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be increased when combined with Somatotropin.]
[A10BF01, acarbose, Somatotropin may decrease the hypoglycemic activities of Acarbose.]
[A10AE06, insulin degludec, The therapeutic efficacy of Insulin degludec can be decreased when used in combination with Somatotropin.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Acipimox.]
[L01CX01, trabectedin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Trabectedin.]
[A10BB31, acetohexamide, Somatotropin may decrease the hypoglycemic activities of Acetohexamide.]
[N05BA08, bromazepam, The metabolism of Bromazepam can be increased when combined with Somatotropin.]
[N04BC01, bromocriptine, Somatotropin may decrease the hypoglycemic activities of Bromocriptine.]
[C03CA02, bumetanide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Bumetanide.]
[N01BB01, bupivacaine, The metabolism of Levobupivacaine can be increased when combined with Somatotropin.]
[S01GX07, azelastine, The metabolism of Azelastine can be increased when combined with Somatotropin.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be increased when combined with Somatotropin.]
[R03DA08, bamifylline, The metabolism of Bamifylline can be increased when combined with Somatotropin.]
[N06BC01, caffeine, The metabolism of Caffeine can be increased when combined with Somatotropin.]
[A10BX06, benfluorex, Somatotropin may decrease the hypoglycemic activities of Benfluorex.]
[L04AB02, infliximab, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Infliximab.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be increased when combined with Somatotropin.]
[J05AG03, efavirenz, The metabolism of Efavirenz can be increased when combined with Somatotropin.]
[A10BJ06, semaglutide, Somatotropin may decrease the hypoglycemic activities of Semaglutide.]
[N01BX04, capsaicin, The metabolism of Capsaicin can be increased when combined with Somatotropin.]
[A10BK04, ertugliflozin, Somatotropin may decrease the hypoglycemic activities of Ertugliflozin.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Captopril.]
[V04CD06, macimorelin, The therapeutic efficacy of Macimorelin can be decreased when used in combination with Somatotropin.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Carbimazole.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be increased when combined with Somatotropin.]
[L01EE03, binimetinib, The metabolism of Binimetinib can be increased when combined with Somatotropin.]
[N03AX17, stiripentol, The metabolism of Stiripentol can be increased when combined with Somatotropin.]
[A10BB06, carbutamide, Somatotropin may decrease the hypoglycemic activities of Carbutamide.]
[R03DA02, oxtriphylline, The metabolism of Oxtriphylline can be increased when combined with Somatotropin.]
[L01AD01, carmustine, The metabolism of Carmustine can be increased when combined with Somatotropin.]
[B01AC23, cilostazol, The serum concentration of Cilostazol can be increased when it is combined with Somatotropin.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ciprofibrate.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be increased when combined with Somatotropin.]
[H02AB14, cloprednol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cloprednol.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ubidecarenone.]
[H02AB17, cortivazol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cortivazol.]
[M03BX08, cyclobenzaprine, The metabolism of Cyclobenzaprine can be increased when combined with Somatotropin.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be increased when combined with Somatotropin.]
[A10AE03, insulin, regular, pork, The therapeutic efficacy of Insulin pork can be decreased when used in combination with Somatotropin.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Daptomycin.]
[H02AB13, deflazacort, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Deflazacort.]
[N02CC07, frovatriptan, The metabolism of Frovatriptan can be increased when combined with Somatotropin.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be increased when combined with Somatotropin.]
[M01AH02, rofecoxib, The metabolism of Rofecoxib can be increased when combined with Somatotropin.]
[D07XB03, fluprednidene, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluprednidene.]
[P01BA01, chloroquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Chloroquine.]
[G03CA06, chlorotrianisene, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Chlorotrianisene.]
[N05AA01, chlorpromazine, The metabolism of Chlorpromazine can be increased when combined with Somatotropin.]
[A10BB02, chlorpropamide, Somatotropin may decrease the hypoglycemic activities of Chlorpropamide.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be increased when combined with Somatotropin.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Etofibrate.]
[N06BA10, fenethylline, The metabolism of Fenethylline can be increased when combined with Somatotropin.]
[A10AF01, insulin, regular, human, The therapeutic efficacy of Insulin human can be decreased when used in combination with Somatotropin.]
[A02BA01, cimetidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cimetidine.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be increased when combined with Somatotropin.]
[S03AA07, ciprofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ciprofloxacin.]
[P01CA03, fexinidazole, The metabolism of Fexinidazole can be increased when combined with Somatotropin.]
[L01XX74, belzutifan, The serum concentration of Belzutifan can be increased when it is combined with Somatotropin.]
[A10BB12, glimepiride, Somatotropin may decrease the hypoglycemic activities of Glimepiride.]
[A10BB08, gliquidone, Somatotropin may decrease the hypoglycemic activities of Gliquidone.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Clofibrate.]
[N01BB10, levobupivacaine, The metabolism of Levobupivacaine can be increased when combined with Somatotropin.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be increased when combined with Somatotropin.]
[S01EA04, clonidine, The metabolism of Clonidine can be increased when combined with Somatotropin.]
[A10BX16, tirzepatide, Somatotropin may decrease the hypoglycemic activities of Tirzepatide.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be increased when combined with Somatotropin.]
[N05AH02, clozapine, The metabolism of Clozapine can be increased when combined with Somatotropin.]
[A10BX01, guar gum, Somatotropin may decrease the hypoglycemic activities of Guar gum.]
[A10BK06, sotagliflozin, Somatotropin may decrease the hypoglycemic activities of Sotagliflozin.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Colchicine.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Leflunomide.]
[A10BX03, nateglinide, Somatotropin may decrease the hypoglycemic activities of Nateglinide.]
[H01AC03, mecasermin, Somatotropin may decrease the hypoglycemic activities of Mecasermin.]
[A10AE04, insulin glargine, The therapeutic efficacy of Insulin glargine can be decreased when used in combination with Somatotropin.]
[R03BA08, ciclesonide, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Ciclesonide.]
[S01AD03, acyclovir, The metabolism of Acyclovir can be increased when combined with Somatotropin.]
[L01EA01, imatinib, The metabolism of Imatinib can be increased when combined with Somatotropin.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Nafarelin.]
[S01BA03, cortisone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Cortisone.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be increased when combined with Somatotropin.]
[S01AE04, lomefloxacin, The metabolism of Lomefloxacin can be increased when combined with Somatotropin.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mebeverine.]
[S01BA08, medrysone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Medrysone.]
[H02AB15, meprednisone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Meprednisone.]
[A10BF02, miglitol, Somatotropin may decrease the hypoglycemic activities of Miglitol.]
[S01XA18, cyclosporine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cyclosporine.]
[C10AA07, rosuvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Rosuvastatin.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cytarabine.]
[J05AF10, entecavir, The metabolism of Entecavir can be increased when combined with Somatotropin.]
[M01AH05, etoricoxib, The metabolism of Etoricoxib can be increased when combined with Somatotropin.]
[L01AX04, dacarbazine, The metabolism of Dacarbazine can be increased when combined with Somatotropin.]
[M01AX01, nabumetone, The metabolism of Nabumetone can be increased when combined with Somatotropin.]
[C01CA23, theodrenaline, The metabolism of Theodrenaline can be increased when combined with Somatotropin.]
[S03BA01, dexamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Dexamethasone.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be increased when combined with Somatotropin.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be increased when combined with Somatotropin.]
[B01AC04, clopidogrel, The metabolism of Clopidogrel can be increased when combined with Somatotropin.]
[C04AD01, pentifylline, The metabolism of Pentifylline can be increased when combined with Somatotropin.]
[S01BC03, diclofenac, The metabolism of Diclofenac can be increased when combined with Somatotropin.]
[A10BG03, pioglitazone, Somatotropin may decrease the hypoglycemic activities of Pioglitazone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be increased when combined with Somatotropin.]
[L02AA01, diethylstilbestrol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Diethylstilbestrol.]
[D07XC04, diflucortolone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Difluocortolone.]
[C02DB01, dihydralazine, The metabolism of Dihydralazine can be increased when combined with Somatotropin.]
[L02AA02, polyestradiol phosphate, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Polyestradiol phosphate.]
[N06BC02, propentofylline, The metabolism of Propentofylline can be increased when combined with Somatotropin.]
[R03DA03, proxyphylline, The metabolism of Proxyphylline can be increased when combined with Somatotropin.]
[C01BA03, disopyramide, Somatotropin may decrease the hypoglycemic activities of Disopyramide.]
[N07XX02, riluzole, The metabolism of Riluzole can be increased when combined with Somatotropin.]
[N01BB09, ropivacaine, The metabolism of Ropivacaine can be increased when combined with Somatotropin.]
[L01EX01, sunitinib, Somatotropin may decrease the hypoglycemic activities of Sunitinib.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be increased when combined with Somatotropin.]
[R03AC12, salmeterol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Salmeterol.]
[A03FA03, domperidone, The metabolism of Domperidone can be increased when combined with Somatotropin.]
[N06AA12, doxepin, The metabolism of Doxepin can be increased when combined with Somatotropin.]
[C10AA01, simvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Simvastatin.]
[J01MA05, temafloxacin, The metabolism of Temafloxacin can be increased when combined with Somatotropin.]
[D01BA02, terbinafine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Terbinafine.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tianeptine.]
[G03CX01, tibolone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Tibolone.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Enalapril.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be increased when combined with Somatotropin.]
[A10AB06, insulin glulisine, human, The therapeutic efficacy of Insulin glulisine can be decreased when used in combination with Somatotropin.]
[N05AX11, zotepine, The metabolism of Zotepine can be increased when combined with Somatotropin.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Iloprost.]
[H05BX01, cinacalcet, The metabolism of Cinacalcet can be increased when combined with Somatotropin.]
[G03CA03, estradiol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estradiol.]
[G03CC06, estriol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Estriol.]
[G03CA57, estrogens, conjugated (USP), The therapeutic efficacy of Somatotropin can be decreased when used in combination with Conjugated estrogens.]
[G03CC04, estrone, The metabolism of Estrone can be increased when combined with Somatotropin.]
[R03BA05, fluticasone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone.]
[C10AA04, fluvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fluvastatin.]
[L02AA03, ethinyl estradiol, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Ethinylestradiol.]
[L01CB01, etoposide, The metabolism of Etoposide can be increased when combined with Somatotropin.]
[L04AD02, tacrolimus, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Tacrolimus.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Nizatidine.]
[N06AB08, fluvoxamine, The metabolism of Fluvoxamine can be increased when combined with Somatotropin.]
[C01BB03, tocainide, The metabolism of Tocainide can be increased when combined with Somatotropin.]
[L02AE02, leuprolide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Leuprolide is combined with Somatotropin.]
[C10AA03, pravastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pravastatin.]
[P02CA03, albendazole, The metabolism of Albendazole can be increased when combined with Somatotropin.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be increased when combined with Somatotropin.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cladribine.]
[C01BC04, flecainide, The metabolism of Flecainide can be increased when combined with Somatotropin.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be increased when combined with Somatotropin.]
[D07AC08, fluocinonide, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluocinonide.]
[H02AB03, fluocortolone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ethanol.]
[S01CB05, fluorometholone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluorometholone.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be increased when combined with Somatotropin.]
[N06AB03, fluoxetine, The metabolism of Fluoxetine can be increased when combined with Somatotropin.]
[L02BB01, flutamide, The metabolism of Flutamide can be increased when combined with Somatotropin.]
[L01BC03, tegafur, The metabolism of Tegafur can be increased when combined with Somatotropin.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Alendronic acid.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ganciclovir.]
[C10AB04, gemfibrozil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Gemfibrozil.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be increased when combined with Somatotropin.]
[C01CA21, cafedrine, The metabolism of Cafedrine can be increased when combined with Somatotropin.]
[A10BJ02, liraglutide, Somatotropin may decrease the hypoglycemic activities of Liraglutide.]
[A10BB01, glyburide, Somatotropin may decrease the hypoglycemic activities of Glyburide.]
[A10BB09, gliclazide, Somatotropin may decrease the hypoglycemic activities of Gliclazide.]
[A10BB07, glipizide, Somatotropin may decrease the hypoglycemic activities of Glipizide.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be increased when combined with Somatotropin.]
[N05AD01, haloperidol, The metabolism of Haloperidol can be increased when combined with Somatotropin.]
[A10AD05, insulin aspart, human, The therapeutic efficacy of Insulin aspart can be decreased when used in combination with Somatotropin.]
[S01BA13, rimexolone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Rimexolone.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Risedronic acid.]
[N06AA02, imipramine, The metabolism of Imipramine can be increased when combined with Somatotropin.]
[L01CD01, paclitaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Paclitaxel.]
[M03BX02, tizanidine, The metabolism of Tizanidine can be increased when combined with Somatotropin.]
[A10BH01, sitagliptin, Somatotropin may decrease the hypoglycemic activities of Sitagliptin.]
[N05CH02, ramelteon, The metabolism of Ramelteon can be increased when combined with Somatotropin.]
[A10BH02, vildagliptin, Somatotropin may decrease the hypoglycemic activities of Vildagliptin.]
[C10AA06, cerivastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Cerivastatin.]
[L01XX35, anagrelide, The metabolism of Anagrelide can be increased when combined with Somatotropin.]
[V03AB01, ipecac, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ipecac.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Stavudine.]
[J05AB13, penciclovir, The metabolism of Penciclovir can be increased when combined with Somatotropin.]
[J04AC01, isoniazid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isoniazid.]
[A10BJ01, exenatide, Somatotropin may decrease the hypoglycemic activities of Exenatide.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ivermectin.]
[M01AG01, mefenamic acid, The metabolism of Mefenamic acid can be increased when combined with Somatotropin.]
[R03BA09, fluticasone furoate, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Fluticasone furoate.]
[N05AH03, olanzapine, The metabolism of Olanzapine can be increased when combined with Somatotropin.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be increased when combined with Somatotropin.]
[C10AA02, lovastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lovastatin.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be increased when combined with Somatotropin.]
[P01BC02, mefloquine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Mefloquine.]
[N05CH01, melatonin, The metabolism of Melatonin can be increased when combined with Somatotropin.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be increased when combined with Somatotropin.]
[A10BA02, metformin, Somatotropin may decrease the hypoglycemic activities of Metformin.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Lamivudine.]
[L01BA04, pemetrexed, The metabolism of Pemetrexed can be increased when combined with Somatotropin.]
[L04AX03, methotrexate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methotrexate.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Methyldopa.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be increased when combined with Somatotropin.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be increased when combined with Somatotropin.]
[A03FA01, metoclopramide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Metoclopramide.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be increased when combined with Somatotropin.]
[N06AX03, mianserin, The metabolism of Mianserin can be increased when combined with Somatotropin.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be increased when combined with Somatotropin.]
[G03XB01, mifepristone, Somatotropin may decrease the hypoglycemic activities of Mifepristone.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Minocycline.]
[C01BD01, amiodarone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be increased when combined with Somatotropin.]
[B02BX05, eltrombopag, The metabolism of Eltrombopag can be increased when combined with Somatotropin.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be increased when combined with Somatotropin.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Raltegravir.]
[N04BC04, ropinirole, The metabolism of Ropinirole can be increased when combined with Somatotropin.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Naltrexone.]
[M02AA12, naproxen, The metabolism of Naproxen can be increased when combined with Somatotropin.]
[A10BG01, troglitazone, Somatotropin may decrease the hypoglycemic activities of Troglitazone.]
[L01CD02, docetaxel, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Docetaxel.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Letrozole.]
[A10BX02, repaglinide, Somatotropin may decrease the hypoglycemic activities of Repaglinide.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Amphotericin B.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Niacin.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be increased when combined with Somatotropin.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Norfloxacin.]
[S02AA16, ofloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ofloxacin.]
[N05AH05, asenapine, The metabolism of Asenapine can be increased when combined with Somatotropin.]
[H02AB05, paramethasone, The therapeutic efficacy of Somatotropin can be decreased when used in combination with Paramethasone.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Penicillamine.]
[C04AD03, pentoxifylline, The metabolism of Pentoxifylline can be increased when combined with Somatotropin.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be increased when combined with Somatotropin.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be increased when combined with Somatotropin.]
[A10BA01, phenformin, Somatotropin may decrease the hypoglycemic activities of Phenformin.]
[N03AB02, phenytoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Phenytoin.]
[N05AG02, pimozide, The metabolism of Pimozide can be increased when combined with Somatotropin.]
[C10AA05, atorvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Atorvastatin.]
[J05AE01, saquinavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Saquinavir.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Eprosartan.]
[J01MA11, grepafloxacin, The metabolism of Grepafloxacin can be increased when combined with Somatotropin.]
[A10BG02, rosiglitazone, Somatotropin may decrease the hypoglycemic activities of Rosiglitazone.]
[A03AE01, alosetron, The metabolism of Alosetron can be increased when combined with Somatotropin.]
[J05AE03, ritonavir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ritonavir.]
[A10BH03, saxagliptin, Somatotropin may decrease the hypoglycemic activities of Saxagliptin.]
[A10AD04, insulin lispro, The therapeutic efficacy of Insulin lispro can be decreased when used in combination with Somatotropin.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Pitavastatin.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be increased when combined with Somatotropin.]
[H02AB07, prednisone, The serum concentration of the active metabolites of Prednisone can be reduced when Prednisone is used in combination with Somatotropin resulting in a loss in efficacy.]
[P01BA03, primaquine, The metabolism of Primaquine can be increased when combined with Somatotropin.]
[C01BA02, procainamide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procainamide.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Fenofibrate.]
[N05AA03, promazine, The metabolism of Promazine can be increased when combined with Somatotropin.]
[C01BC03, propafenone, The metabolism of Propafenone can be increased when combined with Somatotropin.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propofol.]
[C07AA05, propranolol, The serum concentration of Propranolol can be increased when it is combined with Somatotropin.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Propylthiouracil.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Montelukast.]
[P01BC01, quinine, Somatotropin may decrease the hypoglycemic activities of Quinine.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Ranitidine.]
[N04BD01, selegiline, The metabolism of Selegiline can be increased when combined with Somatotropin.]
